Literature DB >> 28855190

Extracellular vesicles as immune mediators in response to kidney injury.

Eva Feigerlová1,2,3,4, Shyue-Fang Battaglia-Hsu1,5, Thierry Hauet3,4,6, Jean-Louis Guéant1,5.   

Abstract

Important progress has been made on cytokine signaling in response to kidney injury in the past decade, especially cytokine signaling mediated by extracellular vesicles (EVs). For example, EVs released by injured renal tubular epithelial cells (TECs) can regulate intercellular communications and influence tissue recovery via both regulating the expression and transferring cytokines, growth factors, as well as other bioactive molecules at the site of injury. The effects of EVs on kidney tissue seem to vary depending on the sources of EVs; however, the literature data are often inconsistent. For example, in rodents EVs derived from mesenchymal stem cells (MSC-EVs) and endothelial progenitor cells (EPC-EVs) can have both beneficial and harmful effects on injured renal tissue. Caution is thus needed in the interpretation of these data as contradictory findings on EVs may not only be related to the origin of EVs, they can also be caused by the different methods used for EV isolation and the physiological and pathological states of the tissues/cells under which they were obtained. Here, we review and discuss our current understanding related to the immunomodulatory function of EVs in renal tubular repair in the hope of encouraging further investigations on mechanisms related to their antiinflammatory and reparative role to better define the therapeutic potential of EVs in renal diseases.

Entities:  

Keywords:  cytokine; exosome; immune modulation; kidney injury; microvesicle; tubular repair

Mesh:

Year:  2017        PMID: 28855190     DOI: 10.1152/ajprenal.00336.2017

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  Ectosome biogenesis and release processes observed by using live-cell dynamic imaging in mammalian glial cells.

Authors:  Mengjiao Sun; Xiufen Xue; Lingyun Li; Dandan Xu; Shihe Li; Shengwen Calvin Li; Qingning Su
Journal:  Quant Imaging Med Surg       Date:  2021-11

2.  Inhibiting uptake of extracellular vesicles derived from senescent bone marrow mesenchymal stem cells by muscle satellite cells attenuates sarcopenia.

Authors:  Hanhao Dai; Wu Zheng; Jun Luo; Guoyu Yu; Chao Song; Yijing Wu; Jie Xu
Journal:  J Orthop Translat       Date:  2022-07-06       Impact factor: 4.889

Review 3.  Stem cells and stem cell-derived extracellular vesicles in acute and chronic kidney diseases: mechanisms of repair.

Authors:  Ciro Tetta; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Ann Transl Med       Date:  2020-04

Review 4.  Application potential of stem/progenitor cell-derived extracellular vesicles in renal diseases.

Authors:  Xiao Sun; Huanyu Meng; Wuqing Wan; Min Xie; Chuan Wen
Journal:  Stem Cell Res Ther       Date:  2019-01-08       Impact factor: 6.832

5.  Molecular and functional profiling of apical versus basolateral small extracellular vesicles derived from primary human proximal tubular epithelial cells under inflammatory conditions.

Authors:  Xiangju Wang; Ray Wilkinson; Katrina Kildey; Jacobus P J Ungerer; Michelle M Hill; Alok K Shah; Ahmed Mohamed; Mriga Dutt; Jeffrey Molendijk; Helen Healy; Andrew J Kassianos
Journal:  J Extracell Vesicles       Date:  2021-02-16

Review 6.  Extracellular vesicles as regulators of kidney function and disease.

Authors:  Felix Behrens; Johannes Holle; Wolfgang M Kuebler; Szandor Simmons
Journal:  Intensive Care Med Exp       Date:  2020-12-18

Review 7.  Proteomics for Biomarker Discovery for Diagnosis and Prognosis of Kidney Transplantation Rejection.

Authors:  Luís M Ramalhete; Rúben Araújo; Aníbal Ferreira; Cecília R C Calado
Journal:  Proteomes       Date:  2022-07-02

Review 8.  Extracellular Vesicles as Mediators of Cellular Crosstalk Between Immune System and Kidney Graft.

Authors:  Marco Quaglia; Sergio Dellepiane; Gabriele Guglielmetti; Guido Merlotti; Giuseppe Castellano; Vincenzo Cantaluppi
Journal:  Front Immunol       Date:  2020-02-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.